Carl Icahn

Bausch Health headquarters formerly Valeant

Pharma

Activist investor Icahn takes 34% interest in Bausch Health

The company discovered the size of activist investor Carl Icahn's economic interest after initiating a "poison pill" plan to ward off unwanted takeovers.

Zoey Becker Apr 22, 2025 6:39pm

'The Top Line': Which biotechs scored big VC dollars in 2022?

Apr 14, 2023 6:00am

If aducanumab fails, Biogen could face activist investor: report

Jun 2, 2021 9:14am

Ironwood names Alex Denner to its board after R&D spinoff

Nov 9, 2020 12:27pm

Allergan swaps director position after investors demand change

Jun 14, 2018 11:45am

Saunders supporter Carl Icahn joins activist party at Allergan

Jun 7, 2018 10:57am